FDA’s Califf Speaks Of Tailoring Trials For CMS Evidence Amid Spotlight On Alzheimer’s Drugs

 
• By Vibha Ravi
US FDA Vector Representation
US FDA Commissioner Robert Califf discussed the value of federated data. • Source: Shutterstock

More from US FDA

More from Agency Leadership